Literature DB >> 10556451

Topical treatments of laparoscopic port sites can decrease the incidence of incision metastasis.

N Eshraghi1, L L Swanstrom, T Bax, B Jobe, K Horvath, B Sheppard, C Deveney.   

Abstract

BACKGROUND: Anecdotal reports of port site tumor recurrence have dampened the enthusiasm for laparoscopic colectomy for cancer. We developed a rat model that creates a high incidence of port site metastasis following laparoscopic intervention. Our goal was to assess the feasibility of minimizing implantations using port site irrigation prior to wound closure.
METHODS: Colon cancer carcinomatosis was established in 46 female BD9 rats using intraperitoneal injections of 10(6) DHD-K12-TRb rat colon cancer cells. This preparation yielded an 81% incidence of port site metastasis in a control group. Laparoscopic sham surgery was performed using four ports and a CO(2) pneumoperitoneum. Four treatment groups were studied by irrigating each port site as follows: Group I, sterile water; group II, normal saline; group III, heparin; group IV, 5-fluorouracil (5-FU). The animals were killed at 4 weeks, and the port sites were examined for tumors.
RESULTS: There were no differences in port site metastasis between controls and groups I, II, and III. The 5-FU group showed a significant decrease (30% vs 81%) in metastasis.
CONCLUSIONS: Port site irrigation with 5-FU at the time of laparoscopy reduces the incidence of port site tumor implantation in a rat colon cancer model. This finding may have utility in patients at high risk of such metastasis who undergo laparoscopy for colon cancer.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10556451     DOI: 10.1007/s004649901186

Source DB:  PubMed          Journal:  Surg Endosc        ISSN: 0930-2794            Impact factor:   4.584


  6 in total

1.  Port-site metastasis after minimally invasive cancer surgery.

Authors:  B Shpitz; E Klein
Journal:  Surg Endosc       Date:  2003-06-13       Impact factor: 4.584

2.  Complications of laparoscopy in benign and oncologic gynecological surgery.

Authors:  Michael J Worley; Brian M Slomovitz; Pedro T Ramirez
Journal:  Rev Obstet Gynecol       Date:  2009

Review 3.  Trocar site recurrence in laparoscopic surgery for colorectal cancer.

Authors:  O Zmora; P Gervaz; S D Wexner
Journal:  Surg Endosc       Date:  2001-06-12       Impact factor: 4.584

Review 4.  Laparoscopic resection of colon Cancer: consensus of the European Association of Endoscopic Surgery (EAES).

Authors:  R Veldkamp; M Gholghesaei; H J Bonjer; D W Meijer; M Buunen; J Jeekel; B Anderberg; M A Cuesta; A Cuschierl; A Fingerhut; J W Fleshman; P J Guillou; E Haglind; J Himpens; C A Jacobi; J J Jakimowicz; F Koeckerling; A M Lacy; E Lezoche; J R Monson; M Morino; E Neugebauer; S D Wexner; R L Whelan
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

Review 5.  Laparoscopic resection of curable colon and rectal cancer: an evidence-based review.

Authors:  T M Young-Fadok; R D Fanelli; R R Price; D B Earle
Journal:  Surg Endosc       Date:  2007-05-05       Impact factor: 3.453

6.  Topical treatment with oxaliplatin for the prevention of port-site metastases in laparoscopic surgery for colorectal cancer.

Authors:  Yun-Sheng Tai; Federico Cuenca Abente; Ahmad Assalia; Kazuki Ueda; Michel Gagner
Journal:  JSLS       Date:  2006 Apr-Jun       Impact factor: 2.172

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.